Verastem launches ‘Reimagine’ campaign to move ovarian cancer drugs into earlier lines
Verastem Oncology has launched a marketing campaign for its co-packaged cancer drugs to drive use of the treatment in earlier lines of therapy.
Verastem Oncology has launched a marketing campaign for its co-packaged cancer drugs to drive use of the treatment in earlier lines of therapy.
Wall Street’s expectations for Bristol Myers Squibb’s upcoming slate of data readouts are reaching a fever pitch. Analysts lobbed questions regarding at least half a
Plus, news about PCI Pharma: 🏭 XTL Bio steps into psychedelics: XTL Biopharmaceuticals is acquiring 100% of the outstanding shares of psychedelic-focused biotech Psyga Bio.
Investors are itching for news on the rollout of Lilly’s oral weight-loss drug Foundayo, but there’s little information in its first-quarter update.
I just came back from the Digital Healthcare Innovation Summit in Boston earlier this week, where I got a good look into what investors are
Talking over pharma pipelines with a major drugmaker’s development chief, he noted that if you looked at the biggest 50 drugs by revenue, the final
Merck is making its pitch that high levels of so-called “bad cholesterol” can increase the risk of heart attack or stroke with its new “Playing
The European Medicines Agency (EMA) has launched an advisory group designed to help boost “vaccine confidence” amid growing hesitancy in the region.
Threats to AbbVie’s immunology dominance took center stage on the company’s first-quarter earnings call Wednesday morning, as analysts pressed executives on their defense strategy. The
The FDA is set to convene its first advisory meeting of oncology experts in about nine months, with a couple of AstraZeneca drugs as the
Copyright 2025 dijee Intelligence Ltd. dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844